NVIDIA Inception startups use AI to improve breast cancer screening and care
NVIDIA highlights four startups in its Inception program that are deploying AI to address critical gaps in breast cancer care, ranging from screening to treatment planning. The initiative responds to a projected shortfall of tens of thousands of radiologists and the current reliance on slow, external genomic assays.
Key points
- iSono Health's ATUSA scans breasts in two minutes, claiming 28% higher sensitivity than handheld ultrasound.
- Whiterabbit.ai's FDA-cleared software assesses breast density and risk to reduce radiologist burden.
- Ataraxis AI predicts treatment response using digital pathology, avoiding separate biopsies.
iSono Health offers ATUSA, an FDA-cleared automated 3D ultrasound system that scans a breast in approximately two minutes, claiming 28% higher sensitivity than handheld 2D ultrasound. Whiterabbit.ai provides FDA-cleared software for assessing breast density and long-term risk, aiming to reduce false alarms and radiologist workload. Ataraxis AI uses digital pathology to predict chemotherapy response and recurrence risk, eliminating the need for separate biopsies in some cases. SimBioSys creates 3D tumor models from multimodal data to guide surgery and treatment decisions.
All four companies utilize NVIDIA GPU infrastructure for training and inference. While some tools are commercially available or in active clinical use, the article notes that certain technologies remain investigational and have not received FDA approval for commercial use.
From Scan to Treatment Plan, AI Helps Close Breast Cancer’s Deadliest Gaps
NVIDIA Blog · 5 October 2026
Loading the full article…
This text was published by NVIDIA Blog and written by Chelsea Sumner. It is reproduced here with attribution so you can read it in full; the rights remain with the publisher. Read it at the source ↗
The headline, key points and digest above were generated by Digest AI's editorial model from the linked sources. Automated summaries can contain errors: the sources are the record. Spotted a mistake? Tell us. Published by Martin K., who runs Digest AI and handles corrections.
More in Enterprise & Industry
All →- Everest Group says enterprise AI shifts from prediction to action · 1 src
- U.S. EHR market to reach $17.43 billion by 2033, report forecasts · 1 src
- OpenAI launches Dots agent for Pro users with limited personal tasks · 3 src
- Anthropic launches in-country Claude inference in India via Amazon Bedrock · 1 src
- FinDialogLens uses GPT-4o to extract trade events from financial chatrooms · 1 src
Comments
via GitHub Discussions